As researchers seek better drugs for breast cancer, they have a revealing new picture that could guide their way. It shows where the breast cancer drug Herceptin binds to and inhibits the protein HER2 on cancer-cell surfaces.
TAKE THAT! This X-ray–based diagram shows where the breast cancer drug Herceptin binds the cancer-cell protein HER2.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.